Search Results - "Insa Molla, A"

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients by Garde-Noguera, J., Martin-Martorell, P., De Julián, M., Perez-Altozano, J., Salvador-Coloma, C., García-Sanchez, J., Insa-Molla, A., Martín, M., Mielgo-Rubio, X., Marin-Liebana, S., Blasco-Cordellat, A., Blasco-Molla, S., Gironés, R., Marquez-Medina, D., Aparisi, F., Cerda, M. C. Bas, Macia-Escalante, S., Sánchez, A., Juan-Vidal, O.

“…Background Immunotherapy increases overall response rate (ORR) and overall survival (OS) in patients with non-small-cell lung cancer (NSCLC). Prognostic and…”
Get full text

LungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients by Garrido Lopez, P., Felip, E., Paz-Ares, L., Majem, M., Moran, T., Gonzalez-Larriba, J.L., Bosch Barrera, J., Trigo Perez, J.M., Garcia Campelo, M.R., Sanchez Torres, J.M., Isla, D., Vinolas Segarra, N., Camps, C., Insa Molla, A., Juan Vidal, O.J., Massutí, B., Paredes Lario, A., Artal-Cortes, A., Lopez-Brea Piqueras, M., Palacios Calvo, J.

Get full text

Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02 by Provencio Pulla, M., de las Peñas, R., Martinez Banaclocha, N., MarsÉ Fabregat, R., Insa Molla, A., Moran, T., Sala Gonzalez, M.A., Massuti Sureda, B., Mut Sanchis, P., Ortega Granados, A.L., Jurado, J.M., Gomez Codina, J., Artal-Cortes, A., Vazquez, F., Gutierrez Calderon, V., Diz Tain, P., Vinolas Segarra, N., Maestu Maiques, I., Camps, C., Isla Casado, M.D.

Get full text

Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients by Garde-Noguera, J., Martin-Martorell, P., De Julián, M., Perez-Altozano, J., Salvador-Coloma, C., García-Sanchez, J., Insa-Molla, A., Martín, M., Mielgo-Rubio, X., Marin-Liebana, S., Blasco-Cordellat, A., Blasco-Molla, S., Gironés, R., Marquez-Medina, D., Aparisi, F., Cerda, M. C. Bas, Macia-Escalante, S., Sánchez, A., Juan-Vidal, O.

“…Clinical and Translational Oncology…”
Get full text

Nonbacterial thrombotic endocarditis associated with lung adenocarcinoma by Martín-Martorell, P, Insa-Molla, A, Chirivella-González, M I, Cervera-Miguel, J I

“…Nonbacterial thrombotic endocarditis (NBTE) is a rather frequent neoplasic complication, most often occurring in adenocarcinomas of the lung and pancreas. The…”
Get full text

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial by Peters, S., Dafni, U., Dómine, M., Popat, S., Andrade, J., Becker, A., Moro-Sibilot, D., Curioni-Fontecedro, A., Molinier, O., Nackaerts, K., Insa Mollá, A., López Vivanco, G., Madelaine, J., Faehling, M., Griesinger, F., González Larriba, J.L., Provencio Pulla, M., Vervita, K., Roschitzki-Voser, H., Ruepp, B., Mitchell, P., Le Pechoux, C., De Ruysscher, D., Stahel, R., Hiltbrunner, A., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schweri, R., Zigomo, I., Tsourti, Z., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Griesinger, F., Tufman, A., de Langen, J., González Larriba, J.L., Insa, A., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R.

“…Concurrent chemotherapy and thoracic radiotherapy followed by prophylactic cranial irradiation (PCI) is the standard treatment in limited-disease small-cell…”
Get full text

1371PFinal results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02 by Provencio Pulla, M, de las Peñas, R, Martinez Banaclocha, N, MarsÉ Fabregat, R, Insa Molla, A, Moran, T, Sala Gonzalez, M A, Massuti Sureda, B, Mut Sanchis, P, Ortega Granados, A L, Jurado, J M, Gomez Codina, J, Artal-Cortes, A, Vazquez, F, Gutierrez Calderon, V, Diz Tain, P, Vinolas Segarra, N, Maestu Maiques, I, Camps, C, Isla Casado, M D

Get full text

121PLungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients by Garrido Lopez, P, Felip, E, Paz-Ares, L, Majem, M, Moran, T, Gonzalez-Larriba, J L, Bosch Barrera, J, Trigo Perez, J M, Garcia Campelo, M R, Sanchez Torres, J M, Isla, D, Vinolas Segarra, N, Camps, C, Insa Molla, A, Juan Vidal, O J, Massutí, B, Paredes Lario, A, Artal-Cortes, A, Lopez-Brea Piqueras, M, Palacios Calvo, J

Get full text

Neo-adjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study” NADIM trial by Calvo de Juan, V., Insa Molla, A., Cobo Dols, M., Massuti Sureda, B., Lopez-Vivanco, G., Casal Rubio, J., de Castro, J., Majem Tarruella, M., Bernabe Caro, R., Gonzalez-Larriba, J., Barneto Aranda, I.C., Nadal, E., Martinez Marti, A., Vinolas Segarra, N., Guillot Morales, M., Vicente Baz, D., Camps Herrero, C., Domine Gomez, M., Rodriguez Abreu, D., Provencio Pulla, M.

Get full text

T790M Resistant Mutation in Plasma of Acquired Resistant EGFR Mutated Non Small Cell Lung Cancer (Nsclc) Patients - The Tarzo Trial (NCT00503971) by Reguart, N., Nadal, E., Molina, M.A., Carcereny, E., Queralt, C., Insa Molla, A., Aguirre, I., Taron, M., Isla Casado, D., Rosell, R.

Get full text

1241P - Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients by Laza-Briviesca, R., Cruz-Bermudez, A., Casarrubios, M., Nadal, E., Molla, M A Insa, García-Campelo, M.-R., Huidobro, G., Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A., De Carpeno, JCastro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E., Bernabé, R., Viñolas, N., Aranda, I C Barneto, Sureda, B Massuti, Provencio, M.

“…Immunotherapy has become the main therapy in advanced NSCLC patients, but recently, combination with chemotherapy in locally advanced stages is showing…”
Get full text

1241PImmune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients by Laza-Briviesca, R, Cruz-Bermudez, A, Casarrubios, M, Nadal, E, Molla, M A Insa, García-Campelo, M-R, Huidobro, G, Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A, Carpeno, J De Castro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E, Bernabé, R, Viñolas, N, Aranda, I C Barneto, Sureda, B Massuti, Provencio, M

“…Abstract Background Immunotherapy has become the main therapy in advanced NSCLC patients, but recently, combination with chemotherapy in locally advanced…”
Get full text

Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients by Laza-Briviesca, R., Cruz-Bermudez, A., Casarrubios, M., Nadal, E., Molla, M A Insa, García-Campelo, M.-R., Huidobro, G., Gomez, M Domine, Tarruella, M Majem, Abreu, D Rodriguez, Martinez-Marti, A., De Carpeno, JCastro, Dols, M Cobo, Vivanco, G López, del Barco Morillo, E., Bernabé, R., Viñolas, N., Aranda, I C Barneto, Sureda, B Massuti, Provencio, M.

Get full text

LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial by Peters, S., Pujol, J-L., Dafni, U., Dómine, M., Becker, A., Andrade, J., Curioni-Fontecedro, A., Molinier, O., Moro-Sibilot, D., Nackaerts, K., Mollá, A. Insa, López Vivanco, G., Madelaine, J., Popat, S., Reck, M., Roschitzki-Voser, H., Mitchell, P., De Ruysscher, D., Le Pechoux, C., Stahel, R.

Get full text

1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy by Lombardi, P., Gambardella, V., Tarazona, N., Carbonell-Asins, J.A., Martín-Arana, J., Rentero-Garrido, P., Montón-Bueno, J.V., Gonzalez-Barrallo, I., Bruixola, G., Cejalvo, J.M., Martín-Martorell, P., Tébar-Martínez, R., Blesa, S., Seda, E., Pérez-Fidalgo, J.A., Insa Mollá, A., Fleitas, T., Zúñiga-Trejos, S., Cervantes, A., Roda, D.

Get full text

Flegmasia cerulea dolens en paciente con carcinoma testicular by Chirivella González, I., Teruel Casasús, A., Magro Molina, A., Insa Mollá, A., Rodríguez Braun, E., Cervantes Ruipérez, A.

Get full text

Phlegmasia cerulea dolens in patients with testicular carcinoma by Chirivella González, I, Teruel Casasús, A, Magro Molina, A, Insa Mollá, A, Rodríguez Braun, E, Cervantes Ruipérez, A

“…We describe a case of phlegmasia cerulea dolens secondary to venous thrombosis due to compression of inferior vena cava, in a 31-year-old man with a germ cell…”
Get full text

Flegmasia cerulea dolens en paciente con carcinoma testicular by Chirivella González, I., Teruel Casasús, A., Magro Molina, A., Insa Mollá, A., Rodríguez Braun, E., Cervantes Ruipérez, A.

“…Describimos un caso de flegmasia cerulea dolens secundaria a una trombosis venosa profunda por compresión de la vena cava inferior, en un varón de 31 años con…”
Get full text